๐๐HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target
Sangamo Therapeutics Reports on Pfizerโs Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia a Gene Therapy Candidate.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
